UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 127

Sortiert nach

The role of steroid hormones in prostate carcinogenesis

Journal of the National Cancer Institute. Monographs, 2000 (27), p.39

Bosland, M C

2000

Volltextzugriff (PDF)

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?

South African medical journal, 2019-03, Vol.109 (3), p.174-177

2019

Volltextzugriff (PDF)

Pathology capacity building in Ghana

Annals of global health, 2015-03, Vol.81 (1), p.139-140

2015

Volltextzugriff (PDF)

Arsenite Is a Cocarcinogen with Solar Ultraviolet Radiation for Mouse Skin: An Animal Model for Arsenic Carcinogenesis

Toxicology and applied pharmacology, 2001-10, Vol.176 (1), p.64-71

2001

Volltextzugriff (PDF)

Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid

The lancet oncology, 2015-08, Vol.16 (8), p.891-892

2015

Volltextzugriff (PDF)

Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages

Science (American Association for the Advancement of Science), 1994-03, Vol.263 (5153), p.1612-1615

1994

Volltextzugriff (PDF)

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial

Cancer prevention research (Philadelphia, Pa.), 2012-02, Vol.5 (2), p.309-319

2012

Volltextzugriff (PDF)

Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience

Journal of Molecular Histology, 2007-05, Vol.38 (2), p.113-121

2007

Volltextzugriff (PDF)

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 909090 target in the population on antiretroviral treatment in Khayelitsha South Africa

South African medical journal, 2019-02, Vol.109 (3), p.174-177

2019

Volltextzugriff (PDF)

A review of human carcinogens—Part A: pharmaceuticals

The lancet oncology, 2009, Vol.10 (1), p.13-14

2009

Volltextzugriff (PDF)

Differential Effects of Selenium on Benign and Malignant Prostate Epithelial Cells: Stimulation of LNCaP Cell Growth by Noncytotoxic, Low Selenite Concentrations

Nutrition and cancer, 2009-01, Vol.61 (2), p.251-264

2009

Volltextzugriff (PDF)

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

The lancet oncology, 2005-08, Vol.6 (8), p.552-553

2005

Volltextzugriff (PDF)

Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models

Progress in clinical and biological research, 1996, Vol.394, p.309

Bosland, M C

1996

Volltextzugriff (PDF)

Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis

Journal of the National Cancer Institute. Monographs, 2000-07, Vol.2000 (27), p.39-66

Bosland, Maarten C.

2000

Volltextzugriff (PDF)

Response: Re: Dietary Fat, Calories, and Prostate Cancer Risk

JNCI : Journal of the National Cancer Institute, 1999-10, Vol.91 (19), p.1692-1693

Bosland, MC

1999

Volltextzugriff (PDF)

The Etiopathogenesis of Prostatic Cancer with Special Reference to Environmental Factors

Advances in Cancer Research, 1988, Vol.51, p.1-106

Bosland, Maarten C.

1988

Volltextzugriff (PDF)

Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein

Urology (Ridgewood, N.J.), 2001-04, Vol.57 (4), p.202-204

2001

Volltextzugriff (PDF)

Vascular endothelial growth factor contributes to the prostate cancer-induced osteoblast differentiation mediated by bone morphogenetic protein. Dai J, Kitagawa Y, Zhang J, Yao Z, Mizokami A, Cheng S, Nor J, McCauley LK, Taichman RS, Keller ET. Department of Pathology, School of Medicine, University Michigan, Ann Arbor, MI.Cancer Res 2004;64:994–9

Urologic oncology, 2004-09, Vol.22 (5), p.437-439

BOSLAND, M

2004

Volltextzugriff (PDF)

Overexpression, amplification, and androgen regulation of TPD52 in prostate cancer. Rubin, MA, Varambally S, Beroukhim R, Tomlins SA, Rhodes DR, Paris PL, Hofer, MD, Storz-Schweizer M, Kuefer R, Fletcher JA, Hsi BL, Byrne JA, Pienta KJ, Collins C, Sellers WR, Chinnaiyan AM, Department of Pathology, Brigham and Women's Hospital, Boston, MA.Cancer Res 2004;64:3814–22

Urologic oncology, 2004-09, Vol.22 (5), p.436-437

BOSLAND, M

2004

Volltextzugriff (PDF)

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Jung C, Kim RS, Lee SJ, Wang C, Jeng MH, Department of Urology, Walther Oncology Center, Indiana University, Indianapolis, IN.Cancer Res 2004;64:3046–51

Urologic oncology, 2004-09, Vol.22 (5), p.440-440

BOSLAND, M

2004

Volltextzugriff (PDF)

Androgen receptor signaling: Mechanism of interleukin-6 inhibition. Jia L, Choong CS, Ricciardelli C, Kim J, Tilley WD, Coetzee GA, Department of Urology and Preventive Medicine, Norris Cancer Center, University of Southern California Keck School of Medicine, Los Angeles, CA.Cancer Res 2004;64:2619-26

Urologic oncology, 2004-09, Vol.22 (5), p.439-440

BOSLAND, M

2004

Volltextzugriff (PDF)

Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5α-dihydrotestosterone and 17β-estradiol

The Prostate, 1995-06, Vol.26 (6), p.325-333

1995

Volltextzugriff (PDF)

Phytoestrogens and prostate cancer: possible preventive role

Medical journal of Australia, 1998-05, Vol.168 (9), p.467-467

1998

Volltextzugriff (PDF)

Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement

The Journal of cell biology, 2005-12, Vol.171 (5), p.835-844

2005

Volltextzugriff (PDF)

Possible enhancement of prostate carcinogenesis by some chemopreventive agents

Journal of cellular biochemistry. Supplement., 1992, Vol.16H, p.135

Bosland, M C

1992

Volltextzugriff (PDF)

1 – 25 von 127

Suche als RSS-Feed

Aktive Filter

ThemaRats

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(109)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

The role of steroid hormones in prostate carcinogenesis

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 90-90-90 target in the population on antiretroviral treatment in Khayelitsha, South Africa?

Pathology capacity building in Ghana

Arsenite Is a Cocarcinogen with Solar Ultraviolet Radiation for Mouse Skin: An Animal Model for Arsenic Carcinogenesis

Carcinogenicity of lindane, DDT, and 2,4-dichlorophenoxyacetic acid

Requirement for Transcription Factor IRF-1 in NO Synthase Induction in Macrophages

Soy isoflavone supplementation for breast cancer risk reduction: a randomized phase II trial

Practical aspects of planning, building, and interpreting tissue microarrays: the Cooperative Prostate Cancer Tissue Resource experience

How accurately do routinely reported HIV viral load suppression proportions reflect progress towards the 909090 target in the population on antiretroviral treatment in Khayelitsha South Africa

A review of human carcinogens—Part A: pharmaceuticals

Differential Effects of Selenium on Benign and Malignant Prostate Epithelial Cells: Stimulation of LNCaP Cell Growth by Noncytotoxic, Low Selenite Concentrations

Carcinogenicity of combined oestrogen-progestagen contraceptives and menopausal treatment

Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models

Chapter 2: The Role of Steroid Hormones in Prostate Carcinogenesis

Response: Re: Dietary Fat, Calories, and Prostate Cancer Risk

The Etiopathogenesis of Prostatic Cancer with Special Reference to Environmental Factors

Chemoprevention trials in men with prostate-specific antigen failure or at high risk for recurrence after radical prostatectomy: Application to efficacy assessment of soy protein

HOXB13 homeodomain protein suppresses the growth of prostate cancer cells by the negative regulation of T-cell factor 4. Jung C, Kim RS, Lee SJ, Wang C, Jeng MH, Department of Urology, Walther Oncology Center, Indiana University, Indianapolis, IN.Cancer Res 2004;64:3046–51

Induction of benign prostatic hyperplasia in intact dogs by near-physiological levels of 5α-dihydrotestosterone and 17β-estradiol

Phytoestrogens and prostate cancer: possible preventive role

Cellular basis of urothelial squamous metaplasia: roles of lineage heterogeneity and cell replacement

Possible enhancement of prostate carcinogenesis by some chemopreventive agents

Aktive Filter

Suchergebnisse filtern